A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
Clinical trial NCT06559163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06559163
- Sponsor
- Zenas BioPharma (USA), LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-17
- Primary completion
- 2026-09-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.